AI vs. pathologists: Which diagnoses cancer better?
Part of Brain & nervous system, Cancer, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study tests a new AI system called COSMO against pathologists to see which is better at diagnosing cancer from digital slides. If you are an experienced pathologist, you will review slides independently, and your results will be compared with the AI's.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a board-certified pathologist with a specialty in neuropathology, lung, or urologic pathology (or general anatomical pathology).
- You need at least 3 years of experience diagnosing tissue slides in a clinical setting.
- You must currently work in a job that involves reading diagnostic pathology slides.
- You agree to review up to 300 digital slide images on a secure platform within a set time frame.
- You cannot have been part of creating or testing the COSMO AI system before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI tool helps pathologists make more accurate diagnoses when looking at tissue samples. It may lead to better and faster diagnoses for patients in the future.
This study uses an AI system to look at your tumor sample and test results to help match you with cancer clinical trials that might be a good fit. It aims to make it easier for doctors to find the most relevant trials for you based on your cancer's specific traits.
This trial uses artificial intelligence to analyze your pathology slides, radiology images, and medical records together. It aims to see how well AI can help with diagnosis or treatment planning, and you may qualify if your medical data is available and of good quality.
This study is testing whether artificial intelligence (AI) can help doctors diagnose diseases from tissue samples more accurately. If you are a pathologist, you'll help compare AI-assisted diagnosis with traditional methods. If you are a patient, your stored tissue samples may be used to test the AI system.
This trial compares treatment recommendations from large language models (AI) against those from experienced tumor boards for five common cancer types. The goal is to see if AI can help doctors make better decisions.
This study is testing whether an artificial intelligence (AI) system can accurately diagnose basal cell carcinoma, a common type of skin cancer, from microscope slide images. If you have had a biopsy slide of a skin lesion that was already diagnosed as basal cell carcinoma, your sample might be used to help train or test the AI.
Hear when a new Brain Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.